文献速递肥胖与代谢综合征糖尿病

代谢健康超重或肥胖成人减重与亚临床颈动脉粥样硬化的队列研究

Weight Change and Development of Subclinical Carotid Atherosclerosis Among Metabolically Healthy Adults: A Cohort Study.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

该队列研究纳入3117例基线无代谢综合征组分及胰岛素抵抗的代谢健康超重或肥胖成人,随访中位3.42年,747例发生亚临床颈动脉粥样硬化。与体重未降或增加者相比,减重0.1%-4.9%者风险降低(HR 0.84,95%CI 0.72-0.98),减重≥5%者风险更低(HR 0.66,95%CI 0.50-0.87)。

要点

  • 代谢健康超重或肥胖成人减重0.1%-4.9%即可降低亚临床颈动脉粥样硬化风险。
  • 减重≥5%者亚临床颈动脉粥样硬化风险进一步降低(HR 0.66)。
  • 代谢健康超重或肥胖人群或可从减重中获得心血管获益。

核心结论

  • 在代谢健康但超重或肥胖的成人中,体重下降与亚临床颈动脉粥样硬化发生率降低相关。
  • 代谢健康超重或肥胖者可能从减重中获得心血管疾病风险方面的获益。

研究设计与样本

  • 队列研究,纳入3117例基线无代谢综合征组分及胰岛素抵抗的代谢健康超重或肥胖成人。
  • 采用颈动脉超声评估亚临床颈动脉粥样硬化,结局为基线无该病者随访期间新发亚临床颈动脉粥样硬化。

主要发现

  • 随访期间747例发生亚临床颈动脉粥样硬化。
  • 随访期间体重未降或增加、减重0.1%-4.9%、减重≥5%者分别占47.0%、44.4%、8.6%。
  • 与体重未降或增加者相比,减重0.1%-4.9%者新发亚临床颈动脉粥样硬化的完全校正HR为0.84(95%CI 0.72-0.98)。
  • 减重≥5%者新发亚临床颈动脉粥样硬化的完全校正HR为0.66(95%CI 0.50-0.87)。

临床怎么用

  • 对代谢健康但超重或肥胖的成人,可将适度减重作为降低心血管风险的干预方向。
  • 减重幅度达到0.1%-4.9%即与亚临床颈动脉粥样硬化风险降低相关,减重≥5%时关联更强。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The benefit of weight loss for reducing cardiovascular disease (CVD) risk in metabolically healthy obese people is unknown. OBJECTIVES: We evaluated the association between weight change and incident subclinical carotid atherosclerosis (SCA) in metabolically healthy but overweight or obese subjects. METHODS: Cohort study of 3117 metabolically healthy overweight or obese adults who did not have any metabolic syndrome components or insulin resistance at baseline. SCA was assessed using carotid artery ultrasonography. The study outcome was the development of incident SCA among participants free of the disease at baseline. RESULTS: During 12 248 person-years of follow-up (median 3.42 years), 747 participants developed SCA. The proportions of participants with no reduction or increased weight, reduction in weight from 0.1% to 4.9%, and reduction in weight ≥ 5% during follow-up were 47.0%, 44.4%, and 8.6%, respectively. The fully-adjusted hazard ratios (HRs) for incident SCA in participants with a reduction in weight of 0.1% to 4.9% and ≥ 5% compared with those with no reduction or increased weight were 0.84 (95% CI, 0.72-0.98) and 0.66 (95% CI, 0.50-0.87), respectively. CONCLUSIONS: In a large cohort study of metabolically healthy but overweight or obese adult men and women, weight reduction was associated with a lower incidence of SCA. Our findings suggest that metabolically healthy overweight or obese subjects may benefit from weight reduction in terms of CVD risk.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Sinn DH, Kang D, Cho SJ, et al. Weight Change and Development of Subclinical Carotid Atherosclerosis Among Metabolically Healthy Adults: A Cohort Study. J Clin Endocrinol Metab. 2020. PMID: 31545359. doi:10.1210/clinem/dgz040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。